Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) dropped 1.8% on Monday . The stock traded as low as $4.89 and last traded at $4.89. Approximately 73,909 shares were traded during trading, an increase of 132% from the average daily volume of 31,898 shares. The stock had previously closed at $4.98.
Ono Pharmaceutical Stock Down 1.8%
The firm has a fifty day simple moving average of $4.88 and a 200-day simple moving average of $4.98.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Further Reading
- Five stocks we like better than Ono Pharmaceutical
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
